Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...

We recently published a list of the 13 Best High Volume Stocks to Buy Now. In this article, we are going to take a look at ...

Although the immediate market response was negative, most pharmaceutical stocks recovered after Wall Street analysts ...

On Wednesday, he visits the House of Representatives. Also on Wednesday, the Consumer Price Index is released. CPI was 2.9% in December on an annual basis and core CPI was 3.2%. Argus forecasts no ...

NEW YORK, April 29, 2025--Pfizer Inc. (NYSE: PFE) reported financial results for the first quarter of 2025 and reaffirmed its 2025 financial guidance(1). NEW YORK, April 26, 2025--Pfizer Inc ...

Market pessimism has undervalued Pfizer and Rexford, both offering high yields and overlooked growth potential. Learn more on ...

In the latest trading session, Pfizer (PFE) closed at $22.15 ... these estimate alterations are directly linked with the stock price performance in the near future. To take advantage of this ...

We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now. In this article, we are ...

The executive order that Donald Trump has signed over the last 24 hours could have a significant effect on pharmaceutical ...

Income investors have liked Pfizer (NYSE: PFE) for years. However ... This approach, often referred to as "most favored ...

In a report released today, Geoff Meacham from Citi maintained a Hold rating on Pfizer (PFE – Research Report), with a price target of $27.00. The company’s shares closed yesterday at $24.54.